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Background: Bile duct adenoma (BDA) is a comparatively rare disease clinically, therefore, there are relatively few
reported cases about it both in China and abroad.
Case presentation: Herein, we present a 51-year-old man, diagnosed preoperatively with enhanced-contrast
abdominal computed tomography, as having a nodule in the left hepatic. The patient underwent a liver tumor
resection, and the histological examination revealed bile duct adenoma (BDA).
Conclusions: BDA is an extremely rare benign tumor, which is difficult to distinguish BDA from hepatocellular
carcinoma definitely preoperatively, surgical resection is needed as a way of treatment.Background
Bile duct adenoma (BDA) is a comparatively rare disease
clinically, therefore, there are relatively few reported cases
about it both in China and abroad. Herein, we report a
case of BDA as well as a literature review, thus presenting
a preliminary analysis on BDA.Case presentation
The patient, a 51-year-old male, was transferred to re-
ceive surgical treatment after he was found to have low
density node on the top of his right liver when receiving
a chest CT examination during his treatment period on
lung infection and cerebral hemorrhage sequelae in the
Department of Neurology. The result of his physical
examination showed no yellow sclerae or positive sign in
his abdomen. The liver function tests were within nor-
mal limits. The serum levels of tumor markers, including
carcinoembryonic antigen (CEA), carbohydrate antigen
(CA) 19-9, and α-fetoprotein (AFP), were not elevated
and the hepatitis virology examination was negative. En-
hanced CT scanning showed low density nodes in his
left hepatic lobe near the top of the liver and an obvious
enhancement of the arterial phase, along with which
there were also the feeding arteries and perifocal hyper-
transfusion with an enhanced drop of venous phase and
delayed phase. Therefore, the left hepatic nodule was* Correspondence: 362795220@qq.com
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reproduction in any medium, provided the orclinically diagnosed with the possibility of liver cancer.
When he was receiving an exploratory laparotomy under
general anesthesia, the patient was also found to have a
medium hard mass measuring about 1.4 cm close to dia-
phragmatic dome in his left hepatic lobe, but the mass
had not infiltrated the liver capsule. The lump was then
completely removed together with the margins at a per-
iphery of 2 cm. The pathological report showed bile duct
adenoma (BDA) and fatty degeneration of hepatic cells,
with the immunohistochemical analysis revealing p53
(−), cytokeratin (CK) 7 (+), CK19 (+), CEA (−), AFP (+),
and epithelial membrane antigen (EMA) (+) (Figures 1,
2, 3, 4 and 5).Discussion
Diagnosis
BDA is a rare case of benign intrahepatic tumor which
is mostly found in patients between the age of 20 to 70
years old, averaging 55 years old, with no significant gen-
der difference in the incidence of this disease [1]. As the
patients often do not present with clinical symptoms,
this tumor is usually discovered by accident during a
physical examination or an autopsy. It is the same case
with the patient of this study: he was found to have liver
occupying lesions unexpectedly when undergoing a chest
CT examination.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 p53 stains were negative.
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As the imaging features of BDA are lacking in specificity,
it is very hard to distinguish BDA from primary liver
cancer. In this case, a plain CT scan showed that there
was a nodular hypodense shadow of 1.5 cm with a hazy
border close to the liver capsule in the juncture of seg-
ment 4 and 8 (Figure 6). The heterogeneity of the en-
hanced arterial phase was more intense; an abnormally
enhanced ring-like peripheral shadow was also observed.
A slightly or moderately enhanced flake-like change was
identified in the hepatic tissue around the lesion, which,
through maximum intensity projection and volumeFigure 2 Strong reactivity for CK7.reconstruction, was shown to get blood supplied by the
branch of the right hepatic artery (Figure 7 and Figure 8)
and the lesions of both the portal and delayed phases
showed a change of low density (Figure 9). The BDA le-
sions in the 6 cases reported by scholars such as Tajima
were detected in the peripheral portion of the liver [2],
and 5 of these took the form of hypervascular tumor,
which are in accordance with the case we are studying.
The CT enhancement method used in our case, how-
ever, is different from those in the cases mentioned
above. This case being studied was initially misdiagnosed
as hepatocellular carcinoma through a preoperative CT
Figure 3 Strong reactivity for CK19.
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strated a typical “quick wash-in and wash-out” sign with
an obvious nodular enhancement in the arterial phase of
the lesion and low density change in the portal and de-
layed phases, all of which made it difficult for accurate
diagnosis. In a report on BDA by Semelka et al., BDA
appeared hypointense on T1-weighted images and hy-
perintense on T2-weighted images through MRI [3].
However, in the report by Maeda et al., T2WI was con-
sidered as hypointense; it was proposed that the differ-
ence is caused by the number of the fibrous tissues inFigure 4 α-fetoprotein stains were weak positive.the tumor and whether there is calcification in the cen-
ter of the tumor [4].
Pathologic diagnosis
Traditionally speaking, BDA is a type of proliferative le-
sion originating from the damaged intrahepatic bile duct
epithelium [5]. The main features of the pathology of
BDA are as follows: i) The lesion is comparatively small,
with a diameter between 1 to 20 mm. ii) The lesion is al-
ways detected under the hepatic capsule, usually taking
the form of solitary nodule, occasionally of multiple
Figure 5 Strong reactivity for epithelial membrane antigen.
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majority of the proliferated bile ducts are observed in
the lesion, accompanied by plenty of chronic inflamma-
tory cell infiltration; the epithelial cells of the prolifer-
ated bile ducts are well differentiated without obvious
atypia. iv) As the disease progresses, the number of pro-
liferated bile ducts and the infiltrated inflammatory cells
gradually decreases, while that of fibrous tissues in-
creases. In the late stage, the hyaline-degenerated colla-
gen fibers occupy the region, with only a small amountFigure 6 Low density nodule with hazy border close to the liver capsof bile component and occasionally accompanied with cal-
cification [6]. v) Immunohistochemical stains for CK7,
CK19, and CD56 are positive, whereas for Ki67 and p53,
stains are negative. In the present case, a large quantity of
proliferated bile ducts can be observed, which are lined
with single cuboidal epithelial cells with considerable in-
flammatory cell infiltration and hepatic steatosis (Figure 10),
in accordance with the above pathological characteristics.
In this case, the weakly positive immunohistochemical
AFP and normal serum AFP show no significance inule in the front part of left liver shown by a plain CT scan.
Figure 7 The enhanced uneven nodule of the lesion in arterial phase with an enhanced ring-like peripheral shadow and congestion
around the lesion.
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gest that the lesion originates from a hamartoma of the
glandular components around the bile ducts, and this
lacking in atypical and gland mutation both contribute
significantly to diagnosis. Further, the variation of the hya-
line cell formation is very similar to renal-cell carcinoma.
However, scholars, such as Saavedra [7], believe that theFigure 8 Maximum intensity projection reconstruction showing the lepositive CK7, EMA, and CEA stains and negative Ki67
and CK20 stains can be helpful for differentiation.
Treatment
Although BDA is defined as a benign tumor, it still has the
possibility of carcinogenesis. Hasebe et al. reported a case
in which BDA developed into cholangiocarcinoma [8].sion blood supply by the branch of right hepatic artery.
Figure 9 Low density shadow of nodule of the lesion in the portal phase.
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guish BDA from hepatocellular carcinoma definitely. Even
when conducting a frozen section examination, it is still
difficult to identify it from cholangiocarcinoma or liver
metastasis. Therefore, surgical resection is still needed as
a way of treatment and local excision is also feasible. Fol-
lowing surgical resection or local excision, patients have a
good prognosis, and so far there is no report about tumor
recurrence in the literature.Figure 10 A large quantity of proliferated bile ducts with considerablConclusions
BDA is an extremely rare benign tumor, which is diffi-
cult to distinguish BDA from hepatocellular carcinoma
through imaging examination .Its main character of
pathological is a large quantity of proliferated bile
ducts, which can be observed in the lesion,They are
CK7, CK19, and EMA immunoreactive, and are p53
and Ki67 negative. Surgical resection is needed as a
way of treatment.e inflammatory cell infiltration can be observed.
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